Literature DB >> 19239919

Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.

Arvind K Jain1, Amit K Goyal, Prem N Gupta, Kapil Khatri, Neeraj Mishra, Abhinav Mehta, Sharad Mangal, Suresh P Vyas.   

Abstract

Poly lactic acid (PLA) is one of widely used biodegradable polymer in vaccine delivery. However, the use is restricted due to hydrophobic nature and generation of acidic microenvironment upon its degradation, rendering it unfavorable to the encapsulated antigen. In the present study we have synthesized PEG derivatized block copolymers of PLA for development of nanoparticles encapsulating HBsAg for mucosal vaccination against hepatitis B. The copolymers of compositions AB, ABA and BAB (PLA as A-block and PEG as B-block) were synthesized and characterized by 1H NMR spectroscopy and gel permeation chromatography. Nanoparticles were characterized to determine the effect of copolymer. Among all, BAB produced nanoparticles of smallest size and lowest zeta potential, suggesting highest PEG density on their surface. The in vitro release experiments were performed in PBS (pH7.4). SDS-PAGE analysis confirmed the structural stability and integrity of the released antigen. Results were compared for immunogenicity with plain PLA nanoparticles and conventional alum-HBsAg based vaccine. BAB nanoparticles produced better humoral response as compared to other polymeric nanoparticles. The extent of humoral response obtained in single dose of BAB nanoparticles was comparable to the response produced by alum based vaccine (which received a booster dose). Block copolymeric nanoparticles also produced better sIgA level at all local and distal mucosal sites as compare of PLA nanoparticles, where alum based formulation failed to give any considerable response. Additionally, IgG1 and IgG2a isotype were determined to confirm the T(H)1/T(H)2 mixed immune response. These data demonstrate the potential of BAB nanoparticles as mucosal vaccine delivery system capable of eliciting high and prolonged immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239919     DOI: 10.1016/j.jconrel.2009.02.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  16 in total

Review 1.  Current prospects and future challenges for nasal vaccine delivery.

Authors:  Helmy Yusuf; Vicky Kett
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

2.  Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination.

Authors:  Xiaoling Zheng; Yongzhuo Huang; Caihong Zheng; Siyu Dong; Wenquan Liang
Journal:  AAPS J       Date:  2010-06-25       Impact factor: 4.009

3.  Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.

Authors:  Chandan Thomas; Vivek Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

Review 4.  Progress towards a needle-free hepatitis B vaccine.

Authors:  Filipa Lebre; Gerrit Borchard; Maria Conceição Pedroso de Lima; Olga Borges
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

5.  Poly(glycerol sebacate) nanoparticles for ocular delivery of sunitinib: physicochemical, cytotoxic and allergic studies.

Authors:  Sana Pirmardvand Chegini; Jaleh Varshosaz; Hamid Mirmohammad Sadeghi; Alireza Dehghani; Mohsen Minayian
Journal:  IET Nanobiotechnol       Date:  2019-12       Impact factor: 1.847

6.  Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.

Authors:  Saurabh Dixit; Shree R Singh; Abebayehu N Yilma; Ronald D Agee; Murtada Taha; Vida A Dennis
Journal:  Nanomedicine       Date:  2014-03-04       Impact factor: 5.307

7.  Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy.

Authors:  Preeti Kumari; Omkara Swami Muddineti; Sri Vishnu Kiran Rompicharla; Pratyusha Ghanta; Adithya Karthik B B N; Balaram Ghosh; Swati Biswas
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 8.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

9.  Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG-PLA micelle.

Authors:  Yanan Shi; Wan Huang; Rongcai Liang; Kaoxiang Sun; Fangxi Zhang; Wanhui Liu; Youxin Li
Journal:  Int J Nanomedicine       Date:  2012-12-27

10.  Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery.

Authors:  Arvind K Jain; Ashley Massey; Helmy Yusuf; Denise M McDonald; Helen O McCarthy; Vicky L Kett
Journal:  Int J Nanomedicine       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.